nafcillin has been researched along with Infective Endocarditis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Catteau, L; Iglesias, YD; Nizet, V; Pogliano, J; Sakoulas, G; Tsunemoto, H; Van Bambeke, F | 1 |
Barber, GR; Barron, MA; Fish, DN; Goolsby, TA; Miller, MA; Moine, P; Mueller, SW | 1 |
Chaparro, J; Davis, C; Murphy, E; Pong, A; Viani, RM | 1 |
Baker, ML; Bisognano, JD; Wormer, D | 1 |
HALL, WH; NYDAHL, BC | 1 |
Archer, GL; Climo, MW; Hale-Cooper, CG; Markowitz, SM; Williams, DS | 1 |
6 other study(ies) available for nafcillin and Infective Endocarditis
Article | Year |
---|---|
Nafcillin Augmentation of Daptomycin and Cathelicidin LL-37 Killing of Methicillin-resistant Staphylococcus epidermidis: Foundations of Successful Therapy of Endocarditis.
Topics: Anti-Bacterial Agents; Cathelicidins; Ceftaroline; Daptomycin; Endocarditis; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Staphylococcus epidermidis | 2023 |
A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cefazolin; Endocarditis; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Nafcillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vascular Grafting; Young Adult | 2020 |
Chest Pain and Shortness of Breath in a Previously Healthy Teenager.
Topics: Abscess; Adolescent; Allografts; Aorta; Aortic Rupture; Aortic Valve; Aortic Valve Insufficiency; Bicuspid Aortic Valve Disease; Cardiac Surgical Procedures; Chest Pain; Drug Resistance, Bacterial; Dyspnea; Endocarditis; Gentamicins; Heart Murmurs; Heart Valve Diseases; Humans; Male; Nafcillin; Pericardial Effusion; Rifampin; Staphylococcal Infections; Staphylococcus lugdunensis; Vancomycin; Vascular Grafting | 2015 |
Thromboembolic events of mitral valve endocarditis.
Topics: Anti-Bacterial Agents; Echocardiography, Doppler, Color; Echocardiography, Transesophageal; Endocarditis; Female; Humans; Mitral Valve; Mitral Valve Insufficiency; Nafcillin; Staphylococcus aureus; Thromboembolism; Treatment Outcome | 2010 |
THE TREATMENT OF STAPHYLOCOCCAL INFECTION WITH NAFCILLIN WITH A DISCUSSION OF STAPHYLOCOCCAL NEPHRITIS.
Topics: Anti-Bacterial Agents; Drug Therapy; Endocarditis; Endocarditis, Subacute Bacterial; Geriatrics; Glomerulonephritis; Heart Valve Prosthesis; Humans; Meningitis; Nafcillin; Nephritis; Penicillins; Pharmacology; Radiography, Thoracic; Sepsis; Staphylococcal Infections; Staphylococcus; Toxicology | 1965 |
Comparison of the in-vitro and in-vivo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal species.
Topics: Animals; Bacteriological Techniques; beta-Lactam Resistance; Ceftizoxime; Drug Resistance, Microbial; Endocarditis; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Rabbits; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Vancomycin | 1997 |